No na Mazduts,ʻike ʻia ʻo IBI362 a i ʻole LY3305677, he agonist ʻelua hou e huli ana i nā mea ʻelua ka glucagon-like peptide-1 receptor (GLP-1R) a me ka glucagon receptor (GCGR). Ke lawelawe nei ma ke ʻano he anti-obesity agent, hoemi ke kaumaha o ke kino, koko koko,ke koko koko, a me ka lehulehu o nā pilikia pili i ka momona.
Ua kūkulu ʻia ka hoʻomohala ʻana o kēia pūhui ma luna o ka ʻike hohonu o oxyntomodulin's physiological kuleana; he hormone ʻōpū kūlohelohe i loaʻa i ka hana ʻelua GLP-1 a me ka hana glucagon. ʻO Mazdutide ponoʻī kahi analog synthetic i loaʻa mai ka oxyntomodulin, me ka hooloihiia momona acyl ʻaoʻao kaulahao i hana ʻia e hoʻolōʻihi i ka lōʻihi o ka hana (hiki i ka hoʻohana ʻana i hoʻokahi pule i hoʻokahi pule).
Ma waho aʻe o ke kaumaha maʻalahi, Ua hōʻike ʻia ka noiʻi e hoʻoulu i ka huna ʻana o ka insulin (i ka iole), hoʻohaʻahaʻa ʻakika uric pae, hoʻomaikaʻi i ke kaumaha oxidative, a ma ka liʻiliʻi loa e hoʻēmi i kekahi nā maʻi maʻi maʻi.
Kaʻina
kona-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Lys-Lys-Ala-Lys-{AEEA-AEEA-γGlu-Nonadecanoic acid}-Glu-Phe-Val-Glu-Trp-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-NH2
Helu CAS
2259884-03-0
ʻĀpana Molekala
C209H319N45O68
Kaumaha Molekala
4563.06
Noiʻi o Mazdutide
1.Hoʻemi kaumaha a hoʻopau i ka makemake
Ua loiloi ʻia kahi noiʻi he 12 pule i nā loli i ka ʻai a me ke kaumaha o ke kino i nā ʻiole i lawelawe ʻia i nā ʻokoʻa o ka mazdutide..
Mea nui, Ua ʻike ʻia ka emi ʻana o ke kaumaha o ke kino, ʻoi aku ka maikaʻi o nā dosis kiʻekiʻe.
Ua hāʻawi ʻia nā ʻāpana histological o ka ate i ke kākoʻo no kēia hopena – ʻO ka steatosis hepatic a me ka mumū e pili ana ua hoʻemi nui ʻia.
Mazdutide-HD (ʻo ke ʻano o ka dose kiʻekiʻe) hōʻike i nā hopena hepatoprotective ikaika loa i hoʻohālikelike ʻia me dulaglutide.
2.Hoʻomaikaʻi ʻia ka hana kaʻa a me ka hana ʻimi ʻimi
Ke hahai nei 30 nā lā o ka hoʻoponopono mau ʻana, Ua hōʻike ʻia nā ʻiole i mālama ʻia me ka mazdutide i ka hoʻomaikaʻi ʻana i ka hiki ke aʻo ma luna o ka pūʻulu mana, me ka hopena i ʻoi aku ka maikaʻi ma mua o ka dulaglutide.
Kākoʻo nā hoʻāʻo hōʻino cognitive i ka hopena therapeutic kūpono o ka mazdutide ma ka hana cognitive.
3.Hoʻomaikaʻi ʻia ka hui ʻana o nā kaʻa, Kaulike a me nā ʻano pili i ka hopohopo
Ua hōʻike ʻia kahi hoʻāʻo ʻana i nā ʻiole i ʻoi aku ka maikaʻi o ka mazdutide (manawa kea a me ka helu o ka holomua) ma mua o nā ʻiole hoʻomalu.
Kākoʻo hou nā hoʻokolohua pili i ka naʻau a me ka hopohopo i kēia mau hopena.
4.Hoʻomaikaʻi a hoʻoponopono i ka pōʻino neuronal a me ka make
ʻO ka hippocampus pili loa i ke aʻo ʻana a me ka hoʻomanaʻo; pili loa ka hana cognitive i kēia mau kaʻina hana.
Hōʻike ka nānā ʻana i ka mōʻaukala o nā ʻāpana neuronal hippocampal i hōʻike ʻia ʻo Mazdutide ma kahi liʻiliʻi e hoʻēmi i kēia ʻano o ka nalowale neuronal..
Ua ʻike pū ʻia ka mālama ʻana i ka lālā dendritic a me nā ana like ʻole o ka nui o ka spine i loko o ka ʻāina hippocampal; ʻO nā hopena neuroprotective kikoʻī i ʻike ʻia ma CA1(Ka pepeiaohao o Amona 1) a me CA3(Ka pepeiaohao o Amona 3) nā subfields i makemake nui ʻia.
5.Kāohi ʻana i ka hōʻemi ʻana o ka Myelin
He kuleana koʻikoʻi ka myelination i ke aʻo ʻana i nā kaʻa, nā pane hoʻololi i nā ʻano ʻano ʻike a pau ma o ka manaʻo mau kaiapuni.
Hāʻawi ʻia ka insulation axonal piha a me ka nui o ke kākoʻo meaʻai no ka hana ʻōnaehana nerve myelin.
ʻO ka hoʻoponopono hou ʻana o Myelin (he kaʻina hana pili loa i ka myelination ʻoiaʻiʻo) he ʻano koʻikoʻi o ke kanaka makua CNS(Pūnaehana Nervous Waena) olakino.
LFB(Luxol Fast Blue) ʻike ʻia ka demyelination o ke kuamoʻo; ua hōʻike ka hui mazdutide i nā pū myelin i hoʻonohonoho pono ʻia, ʻO ka demyelination liʻiliʻi ka hopena pololei o ka lāʻau.
ʻO ka mālama ʻana i ka ʻoiaʻiʻo o ka myelin i kēia manawa ke manaʻo ʻia nei he pahuhopu kūpono – lohi ka hoʻomaka ʻana a me ka holomua lohi o ʻO ka maʻi o Alzheimer ʻo ia kekahi o nā pahuhopu lapaʻau maikaʻi loa o ia noiʻi.
COA
HPLC
MS





